Hyundai Pharmaceutical Co., Ltd.
KSC: 004310.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sang-Jun Lee
- Employees
- 385
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩209.1B
- Website
- https://www.hyundaipharm.co.kr
Loading 004310…
Loading profile data…Frequently asked questions about 004310
What does Hyundai Pharmaceutical Co., Ltd. (004310.KS) do?
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antih...
Where does 004310.KS trade?
Hyundai Pharmaceutical Co., Ltd. (004310.KS) trades on the Korea Exchange.
What sector is 004310.KS in?
Hyundai Pharmaceutical Co., Ltd. (004310.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hyundai Pharmaceutical Co., Ltd.?
Sang-Jun Lee is the chief executive officer of Hyundai Pharmaceutical Co., Ltd. (004310.KS).
Where is Hyundai Pharmaceutical Co., Ltd. headquartered?
Hyundai Pharmaceutical Co., Ltd. is headquartered in South Korea.
Does 004310.KS pay a dividend?
Yes — Hyundai Pharmaceutical Co., Ltd. (004310.KS) paid a trailing twelve-month dividend of KRW 30.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 004310.KS go public?
Hyundai Pharmaceutical Co., Ltd. (004310.KS) completed its initial public offering in 2000.